Patent details

EP1617862 Title: Botulinum neurotoxin for treating obsessive compulsive behavior symptoms

Basic Information

Publication number:
EP1617862
PCT Application Number:
PCT/US/2004/011959
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047502992
PCT Publication Number:
WO/2004/096269
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Botulinum neurotoxin for treating obsessive compulsive behavior symptoms
French Title of Invention:
Neurotoxine botulique pour le traitment des symptomes de comportements compulsifs obsedants
German Title of Invention:
Botulinum Neurotoxin zur Behandlung von Äobsessive compulsive behaviorsÄ Symptomen
SPC Number:

Dates

Filing date:
16/04/2004
Grant date:
05/12/2012
EP Publication Date:
05/12/2012
PCT Publication Date:
11/11/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/01/2006
EP B1 Publication Date:
05/12/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
16/04/2013
Expiration date:
16/04/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/04/2004
 
 

Name:
ALLERGAN INC.
Address:
2525 Dupont Drive, Irvine CA 92612, United States (US)

Inventor

Name:
ACKERMAN Alan, H.
Address:
United States (US)

Priority

1

Priority Number:
424009
Priority Date:
25/04/2003
Priority Country:
United States (US)

2

Priority Number:
423778
Priority Date:
25/04/2003
Priority Country:
United States (US)

3

Priority Number:
423380
Priority Date:
25/04/2003
Priority Country:
United States (US)

4

Priority Number:
424050
Priority Date:
25/04/2003
Priority Country:
United States (US)

5

Priority Number:
423384
Priority Date:
25/04/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/48;
Filing date Document type Number of pages